FDA.reportPublic FDA data

HERCESSI 150 MG Injection

RxCUI
2700724
RxNorm name
HERCESSI 150 MG Injection
Display name
HERCESSI 150 MG Injection
Full name
HERCESSI 150 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761346Hercessitrastuzumab-strf351(k) BiosimilarRx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
285d2142-5bfa-401c-9246-7de21c4451afHERCESSI 150 MG Injection [PSN] · trastuzumab-strf 150 MG Injection [Hercessi] [SBD] · Hercessi 150 MG Injection [SY]34These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab).20250321